Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer

NCT05565378

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • GSK Investigational Site Plantation, Florida, United States
  • GSK Investigational Site Albuquerque, New Mexico, United States
  • GSK Investigational Site Chattanooga, Tennessee, United States
  • GSK Investigational Site Morgantown, West Virginia, United States
View all 99 locations
View Trial Details
Active, Not Recruiting

Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations

NCT05215340

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • UCLA HemOnc - Clinical Research Unit Los Angeles, California, United States
  • Ridley-Tree Cancer Center Santa Barbara, California, United States
  • PIH Health Whittier Hospital Whittier, California, United States
View all 234 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations

NCT05801029

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Hong Kong
  • Research Site Hong Kong
  • Research Site Hong Kong
  • Research Site Shatin, Hong Kong
View all 29 locations
View Trial Details
Active, Not Recruiting

Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer

NCT02393625

Conditions
ALK-positive NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Massachusetts General Hospital Thoracic Oncolgoy Boston, Massachusetts, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) Mutation Positive Non-small Cell Lung Cancer

NCT02503722

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • BCCA-Vancouver Cancer Centre Vancouver, British Columbia, Canada
View Trial Details
Active, Not Recruiting

First in Human Study of AZD9592 in Solid Tumors

NCT05647122

Conditions
Advanced Solid Tumours, Bronchial Neoplasms, Carcinoma Non-small Cell Lung, +19 more
Locations
  • Research Site Duarte, California, United States
  • Research Site North Haven, Connecticut, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Chicago, Illinois, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone

NCT03040973

Conditions
Advanced Solid Tumors Which Are cMET-dependent, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Edmonton, Alberta, Canada
  • Novartis Investigative Site Shanghai, Shanghai Municipality, China
View all 15 locations
View Trial Details
Active, Not Recruiting

S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer

NCT04155034

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Carcinoma, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
View all 446 locations
View Trial Details

Related conditions